Irkutsk anti-plague institute death prompts quarantines and conflicting official accounts.
|Articles|July 30, 2020
Herman Cain Passes After 3-Week Coronavirus Battle
Author(s)Grant M. Gallagher
On Tuesday, Cain was said to be recovering, possibly reflecting the complex immune system stages of COVID-19 disease course.
Advertisement
This story is in development. Updates will be provided as information emerges.
Herman Cain, business executive and former presidential candidate, has died of COVID-19. Cain previously survived cancer and was 74 years of age.
The announcement was made by Dan Calabrese on Cain's website.
"We knew when he was first hospitalized with COVID-19 that this was going to be a rough fight. He had trouble breathing and was taken to the hospital by ambulance. We all prayed that the initial meds they gave him would get his breathing back to normal, but it became clear pretty quickly that he was in for a battle," Calabrese reported.
Cain was admitted to an Atlanta, Georgia area hospital on July 1, after testing positive for SARS-CoV-2 several days prior.
On Tuesday, Cain was said to be
"We didn’t release detailed updates on his condition to the public or to the media because neither his family nor we thought there was any reason for that. There were hopeful indicators, including a mere five days ago when doctors told us they thought he would eventually recover, although it wouldn’t be quick. We were relieved to be told that, and passed on the news via Herman’s social media. And yet we also felt real concern about the fact that he never quite seemed to get to the point where the doctors could advance him to the recovery phase," Calabrese said.
Cain was reportedly planning a new television series on Newsmax in the weeks before his death. Cain is survived by his wife, children, and grandchildren.
Advertisement
Related to this article
A laboratory technician at a Siberian anti-plague institute has died of pneumonia of unknown cause, prompting quarantines and contact monitoring while Russian officials stop short of confirming plague.
A study finding clesrovimab comparable to palivizumab in protecting at-risk infants in their first RSV season was extended to demonstrate clesrovimab effective and well-tolerated when administered in their second season.
In the phase 3 LIBERTY study, the investigational monoclonal antibody, VYD2311, had significantly fewer adverse events than an mRNA COVID-19 vaccine, and it did not blunt vaccine-induced neutralizing titers when the two were given together.
Reported cases of Legionnaires’ disease have been on the rise for the past decade, and identifying Legionella bacteria requires specialized testing in the microbiology lab. Here is a clinical overview of Legionella bacteria, including required testing, treatment, and reporting to public health officials.
The 18-year old resident of the state suffered from acute disseminated encephalomyelitis. Pennsylvania numbers are surging with some of the highest state totals of measles cases in the country.
In its second disease cluster this summer, city officials are cleaning building towers in the South Bronx amidst an ongoing investigation and are rolling out measures to prevent future Legionnaires' cases.
The death was reported in Jefferson County where the coroner released a statement announcing it was in an unvaccinated woman.
Advertisement
Advertisement